<DOC>
	<DOCNO>NCT02180906</DOCNO>
	<brief_summary>The purpose study investigate immune response patient necrotizing soft tissue infection ( NSTI ) . The investigation focus inflammatory vasoactive biomarkers prognostic marker severity mortality admission Rigshospitalet follow 3 day</brief_summary>
	<brief_title>Biomarkers Patients With Flesh-eating Bacterial Infections</brief_title>
	<detailed_description>Necrotizing soft tissue infection ( NSTI ) complex , multi-factorial disease diverse microbiological etiology vary co-morbidities . The rapidly spreading infection may cause extensive soft tissue damage , limb loss , multiple organ failure . The incidence NSTIs increase past year fatality rate still high despite increased focus patient ( 20-30 % ) . The extensive inflammatory response think main course death . However , unknown biomarkers responsible deleterious effect molecular mediator modulate infection treatment regime . Thus , need novel insight immune system disturbances order improve outcome NSTIs . Location : Copenhagen University Hospital , Rigshospitalet , Denmark . Design : Observational cohort study . Cohort : NSTI patient Denmark . Controls : 50-100 Patients undergo elective , orthopedic surgery Rigshospitalet . Biomarkers : The investigator focus three major group biomarkers : Acute-phase protein , cytokine vasoactive biomarkers . Sample size calculation : 1 . Acute-phase protein : The investigator expect mean PTX3-concentration admission 120 nmol/L patient without septic shock mean PTX3-concentration 210 nmol/L patient septic shock . With estimate standard deviation 100 nmol/L , inclusion 52 patient able detect significant difference statistical power 90 % 5 % significance level . Since group unequal investigator need include 82 patient ( N'=52 ( 1+4 ) ^2/4*4 ) . 2 . Cytokines : In pilot study seven NSTI patient , investigator find minimal clinically relevant difference IL-6 concentration NSTI patient LRINEC &lt; 6 ≥ 6 1050 pg/ml . With estimate standard deviation 2000 pg/ml , inclusion 114 patient able detect significant difference statistical power 80 % 5 % significance level . 3 . Vasoactive protein : The investigator expect mean NOx-concentration admission 90 μmol/L patient without septic shock mean NOx-concentration 145 μmol/Lin patient septic shock . With estimate standard deviation 70 μmol/L , inclusion 70 patient able detect significant difference statistical power 90 % 5 % significance level . Since group unequal investigator need include 110 patient ( N'=70 ( 1+4 ) ^2/4*4 ) . Data : Data handle accord National Data Protection Agency . All original record ( incl . consent form questionnaire ) archive trial site 15 year . The National Data Protection Agency approve biobank ( 2007-58-0015 , J. nr . 30-1282 ) . Ethics : The trial adhere Helsinki Declaration Danish law . The National Ethics Committee Regional Ethics Committee approve inclusion NSTI patient ( CVK-1211709 ) control patient , include biomarker analysis ( H-2-2014-071 ) . Biomarker analyse , data extraction interpretation perform recruiting participant end .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Fasciitis</mesh_term>
	<mesh_term>Soft Tissue Infections</mesh_term>
	<mesh_term>Gangrene</mesh_term>
	<mesh_term>Fasciitis , Necrotizing</mesh_term>
	<mesh_term>Fournier Gangrene</mesh_term>
	<mesh_term>Gas Gangrene</mesh_term>
	<criteria>Inclusion Criteria patient NSTI : Necrotizing soft tissue infection base surgical finding Age &gt; 18 year Admitted to/planned admitted ICU Rigshospitalet and/or operate NSTI Rigshospitalet Exclusion Criteria patient NSTI : Patients operate theatre categorize nonNSTI patient Inclusion Criteria control patient : Patients undergo elective orthopedic surgery ( nonpathologic fracture , joint replacement surgery , back surgery ) Rigshospitalet Age &gt; 18 year Exclusion Criteria control patient : Patients ongoing infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Fasciitis</keyword>
	<keyword>Gangrene</keyword>
	<keyword>Fasciitis , Necrotizing</keyword>
	<keyword>Soft Tissue Infections</keyword>
	<keyword>Fournier 's Gangrene</keyword>
	<keyword>Streptococcal septic shock syndrome</keyword>
	<keyword>Flesh eating bacteria</keyword>
	<keyword>Meleneys ulcer</keyword>
	<keyword>Wounds Injuries</keyword>
	<keyword>Streptococcus pyogenes</keyword>
	<keyword>Staphylococcus aureus</keyword>
	<keyword>Immunopathogenesis</keyword>
	<keyword>Soft Tissue Infections/blood</keyword>
	<keyword>Necrosis/blood</keyword>
	<keyword>Necrosis/diagnosis</keyword>
	<keyword>Necrosis/mortality</keyword>
	<keyword>Necrosis/surgery</keyword>
	<keyword>Prognosis</keyword>
	<keyword>Risk Factors</keyword>
	<keyword>Bacterial Infections</keyword>
	<keyword>Infection</keyword>
	<keyword>Skin Diseases , Bacterial</keyword>
	<keyword>Observational study</keyword>
	<keyword>Biological marker</keyword>
</DOC>